This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceuticalcompany Regeneron has invested $119.5
More than a decade ago, Ken Mandl was on a call with a pharmaceuticalcompany and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test. The test could determine a patient’s need for a helpful drug.
Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.
government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceuticalcompany has been threatened with such a step , STAT tells us.
The biologics market is expected to grow to more than $670 billion(iv) by 2030, and for pharmaceuticalcompanies developing these complex drugs, the BD Libertas Wearable Injector offers a customisable, patient-centric solution.
The gathering brought together senior representatives from hospitals, pharmaceuticalcompanies, policymakers, and ESG leaders, including Fortis, Apollo, Quadria Capital, and Tata Capital Healthcare Fund. The report was released at an event held in New Delhi, supported by Quadria Capital and HealthQuad.
Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceuticalcompany. At week 4, 22.5 percent of patients taking SPRAVATO achieved remission. This was compared to 7.6
A federal court in Missouri has dismissed a legal challenge by drugmaker AbbVie to the state’s new 340B contract pharmacy law, which aims to regulate how pharmaceuticalcompanies interact with contract pharmacies. The order, filed July 11 in the U.S.
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen PharmaceuticalCompanies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
The hospitals and the payment plans would not use your generic drug if you weren’t therapeutically equivalent—we would exclude you,” Soefje said. In 2022, based upon a complaint filed by a pharmaceuticalcompany, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said.
government sent pricing inquiry letters to 17 major pharmaceuticalcompanies. This action didn’t just raise eyebrows—it sent shockwaves across the entire pharmaceutical industry, particularly among marketing and pricing strategists. Imagine being handed a letter that could redefine your business model overnight.
Beyfortus cut RSV hospitalizations by up to 83.2% For instance, an immunization program that was executed in Spain using Beyfortus reportedly reduced infant hospitalizations due to RSV by 69.0% For instance, an immunization program that was executed in Spain using Beyfortus reportedly reduced infant hospitalizations due to RSV by 69.0%
The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. Aimed at providing discounted drugs to hospitals in lower income areas, pharma leaders argue the program is vulnerable to abuse and sometimes boosts hospital profits without helping patients.
Large pharmaceuticalcompanies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51
Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceuticalcompany ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.
The technology is rapidly gaining traction among doctors in India, while internationally, institutions like Hungarys Heim Pl National Paediatric Institute, one of the largest paediatric hospitals has adopted N-FIS to enhance patient care.
Joshua E Allen, chief scientific officer of Chimerix, a Jazz Pharmaceuticalscompany, stated: “The FDA approval of Modeyso is a milestone moment for the patients and families who have long needed new options, the clinicians who have tirelessly searched for solutions, and the researchers and advocates who never gave up.”
Real-World Applications and Success Metrics TAP Native’s retargeting solution has been instrumental in various healthcare marketing scenarios: Pharmaceutical Marketing : By retargeting HCPs who have shown interest in specific drug classes, pharmaceuticalcompanies can reinforce brand awareness and encourage prescription behavior.
The initiative comes at a crucial time, as British pharmaceuticalcompanies are significantly increasing their investments in the United States. Outlaid via the Life Sciences Innovative Manufacturing Fund (LSMIF), the investment will aim to expand the UK’s manufacturing capabilities and supply chain security.
More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceuticalcompanies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US. Give your business an edge with our leading industry insights.
Zentiva Group has entered into a licence and supply agreement with pharmaceuticalcompany Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets. Credit: Zentiva Group, a.s.
Imagine the waste generated in the pharmaceuticalcompanies and the hospitals every day. Those having worked in manufacturing of pharmaceutical products and hospitals would know this. I can keep on adding even to the medical devices. is the largest consumer of plastics.
The HHS secretary has said the restructuring will reduce conflicts of interest with pharmaceuticalcompanies. greenlights removal of preservative in flu shots appeared first on Becker's Hospital Review | Healthcare News & Analysis. The post RFK Jr.
Jacqueline Durett Few times in the evolution of a pharmaceuticalcompany are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market.
According to ICMR, infections that were once easily treatable are now becoming resistant to widely used antibiotics, leading to prolonged hospital stays, higher mortality rates, and rising healthcare costs. This creates little financial incentive for pharmaceuticalcompanies to invest in antibiotic research.
The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceuticalcompany to disclose plans to change the way it will make payments. Right now, drug companies generally provide the discounts at the time of purchase.
Our geographical region is very large with 100 hospitals spread across almost 70,000 square miles, with huge distances between each one, yet only one hospital has the skillset needed to deliver CAR-T cell therapies.
Thus, if you are a healthcare or pharmaceuticalcompany that still hasn’t implemented any business intelligence tools, now is the best time to consider them. Moreover, healthcare BI allows hospitals to plan their activities better and find out more about how well they perform and what they could change.
This report looks at marketed therapies and their sales projections, pipeline drug trends, and key development challenges for pharmaceuticalcompanies, as well as the role of CDMOs in targeted modality development and what to look for in a development and manufacturing partner. You will receive an email shortly.
Supporting sterile barrier packaging and supply chain resilience The Madison plant reinforces the TekniPlex Healthcare’s goal of assisting pharma and medical companies, which indirectly includes its downstream partners as well. Otherwise, they run the risk of becoming obsolete and facing a need for substantial investment in new equipment.”
Find out more This trade deal puts the pharmaceutical industry at risk of losing between $13bn and $19bn, with consequences that extend beyond short-term financials. This could hinder innovation and pipeline investment, reducing the much-needed pace of therapeutic innovation across the industry.
The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceuticalcompanies to invest in the country. Give your business an edge with our leading industry insights.
He also sent letters to 17 pharmaceuticalcompanies, calling for them to lower drug prices by Sept. The post Trump floats 250% tariff on drug imports appeared first on Becker's Hospital Review | Healthcare News & Analysis. 29, including offering their full lines of medicines to Medicaid patients.
RSV can lead to hospitalization or worse, particularly for those with certain chronic conditions. This leads to an estimated 177,000 hospitalizations in U.S. adults aged 65 and older annually, while an estimated 14,000 of hospitalizations result in death. Prevention starts with awareness—and that first step is a conversation.”
Katarina Zahedi, pharma analyst at GlobalData, comments: “These investments reflect a growing trend among pharmaceuticalcompanies to bolster domestic operations in response to geopolitical pressures and potential tariffs on imported pharmaceuticals.” Give your business an edge with our leading industry insights.
Schleifer added in the conference call that the facility was involved in the production of 70 billion doses last year, conducting business “with the vast majority of the top bio-pharmaceuticalcompanies in the world.” As a result, Schleifer added that Regeneron may not be the only company affected by the inspection. “I
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceuticalcompanies, the insurance companies, all make money by keeping us sick. We need to fundamentally change that so that we are focusing on curing disease and making people better.”
Earlier this summer, President Donald Trump urged pharmaceuticalcompanies to align U.S. The post Pfizer, BMS offer direct-to-patient Eliquis at 40% discount appeared first on Becker's Hospital Review | Healthcare News & Analysis.
R&D budgets of pharmaceuticalcompanies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds.
It feels like in the US, pharmaceuticalcompanies are capitalising on people’s frustration and desperation to lose weight.” “I don’t understand why medication costs are so much higher in the US compared to Europe, though I’ve noticed prices can vary across European countries too,” said Helena. “It
By GlobalData Learn more about Strategic Intelligence ‘Middlemen’ or pharmacy benefit managers (PBMs) are often blamed by the pharmaceuticalcompanies for high drug prices. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content